Baguio Green Group (01397.HK) Announces 2024 Annual Results with Net Profit hits Historical High since listing
Favorable policies driving rapid growth HONG KONG, March 27, 2025 /PRNewswire/ -- Baguio Green Group Limited (''Baguio'' or the ''Group'', Stock Code: 01397.HK) is pleased to announce its annual results for the year ended 31 December 2024 (the...
Yeahka Announces 2024 Annual Results
AI applications empowered product ecosystem Stellar growth overseas across Asia More robust business models with enhanced profitability HONG KONG, March 27, 2025 /PRNewswire/ -- Yeahka Limited ("Yeahka" or the "Company," Stock Code: 9923.HK), a...
Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D
Highlights of Annual Results for the Year Ended December 31, 2024 Revenue reached RMB1,986.7 million Gross profit amounted to RMB687.4 million Net profit recorded RMB222.0 million, a significant turnaround from a year ago Adjusted Non-IFRS net...
JuCoin Announces Taiwan Market Entry: Leading Web3's Future Through Regulatory Compliance and Ecosystem Development
JuCoin formally applies for regulatory licenses, builds KYC system, and commits 200 million TWD to empower Taiwan's community SINGAPORE, March 27, 2025 /PRNewswire/ -- Embracing Regulation - JuCoin Aligns with Taiwan's New Crypto Policies Taiwan is...
EYNESBURY CENTRAL LAND PTY LTD ANNOUNCES OFFERING OF AUD 99,075,261 SENIOR SECURED LOAN NOTE OFFER
MELBOURNE, Australia, March 27, 2025 /PRNewswire/ -- Eynesbury Central Land Pty Ltd ACN 649 293 032 is seeking to raise a total of AUD 99,075,261 in funds by the issue of loan notes, according to an announcement today by the underwriter Banner...
AnHorn Medicines Announces First Subject Dosed in AH-001 Phase I Clinical Trial in the United States
TAIPEI, March 27, 2025 /PRNewswire/ -- AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androgenetic alopecia (AGA), has officially entered Phase I...
Keymed Biosciences Announces Annual Results of 2024
CHENGDU, China, March 26, 2025 /PRNewswire/ -- March. 25, 2025, Keymed Biosciences Inc. (HKEX: 02162) announced its annual results of 2024, along with a corporate update. Rapid development of our pipeline products Stapokibart (CM310) (IL-4Rα...
TOYO Co., Ltd Announces Plans for Additional 2GW Solar Cell Capacity Expansion in Ethiopia
TOKYO, March 26, 2025 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF) ("TOYO" or the "Company"), a solar solution company, is excited to announce it will begin building an additional 2 gigawatts (GW) expansion of its solar cell capacity at...
NetDragon Announces 2024 Annual Financial Results, Fully Embraces the World of Artificial Intelligence
Profit Before Tax Up 19% YoY Final Dividend Increased by 25% YoY to HK$ 0.5 Per Share HONG KONG, March 26, 2025 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or the "Company"; Hong Kong Stock Code: 0777), a global leader in...
Innovent Announces 2024 Annual Results and Business Updates
First-ever positive profit, entering a new era of growth and global innovation SAN FRANSISCO and SUZHOU, China, March 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops,...